Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Scientists develop cancer-fighting robots
Magnified algae with magnetic coating.

Devices pave way for the development of new treatments

Scientists have developed tiny, remote-controlled robots that release cancer-fighting compounds. It is hoped that the robots may someday be used to diagnose and treat illness in areas of the human body that are difficult to reach.

Developed by an international team of researchers, the ‘micro-robots’ are coated in microscopic algae with non-harmful, biocompatible magnetic particles. The devices are about the size of a blood cell and can swim in biological fluids, such as dilute blood and gastric fluid.

In experiments with rats, scientists used magnets to guide the robots to sites in the stomach. They could be tracked in tissue close to the surface of the skin by imaging the algae’s natural luminescence. In harder-to-reach tissue, they could be tracked using an MRI scanner.

Besides delivering drugs to areas of the body that are hard-to-reach, scientists say the robots could also sense chemical changes linked to the onset of illness. This could one day make them useful as probes for remote diagnosis.

The devices biodegrade within the body and can take more or less time depending on the thickness of their manufactured coating.
Qi Zhou, of the University of Edinburgh’s School of Engineering, who worked on the study, said:

“A small-scale robot that can be remotely guided, is easily tracked and harmlessly biodegrades, potentially overcomes many of the challenges faced by minimally invasive therapies. We hope our discoveries will pave the way for the development of useful diagnostics or treatments.”

The study, published in Science Robotics, was carried out in collaboration with the Universities of Edinburgh and Manchester.

Image (C) Yan et al Science Robotics 2017.

Become a member or log in to add this story to your CPD history

Equine Disease Surveillance report released for Q4 2025

News Story 1
 The latest Equine Disease Surveillance report has been released, with details on equine disease from Q4 of 2025.

The report, produced by Equine Infectious Disease Surveillance, includes advice on rule changes for equine influenza vaccination.

Statistics and maps detail recent outbreaks of equine herpes virus, equine influenza, equine strangles and equine grass sickness. A series of laboratory reports provides data on virology, bacteriology, parasitology and toxicosis.

This issue also features a case study of orthoflavivus-associated neurological disease in a horse in the UK. 

Click here for more...
News Shorts
BSAVA announces 12th Edition of the Small Animal Formulary

The BSAVA has published an updated edition of its Small Animal Formulary, which includes new drug monographs and emergency drug doses for rabbits, rodents, birds and reptiles.

One of BSAVA's most trusted and widely used clinical resources, this 12th edition of the manual also includes seven new client information leaflets and information on drugs used for the management of urinary incontinence.

Part A of the Formulary, Canine and Feline, sees Fergus Allerton return as Editor-in-Chief, while Part B: Exotic Pets was edited by Joanna Hedley. For more information, visit the BSAVA website.